SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-013432
Filing Date
2024-02-13
Accepted
2024-02-13 17:18:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea193651-13ga1murphy_cadren.htm SC 13G/A 110241
  Complete submission text file 0001213900-24-013432.txt   111574
Mailing Address 233 S PATTERSON AVE SPRINGFIELD MO 65802
Business Address
MURPHY JOHN RAYMOND (Filed by) CIK: 0001275195 (see all company filings)

Type: SC 13G/A

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Subject) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94027 | Film No.: 24630034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)